35 filings
8-K
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
8-K
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
8-K
PNT
POINT Biopharma Global Inc.
14 Aug 23
POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
7:21am
8-K
PNT
POINT Biopharma Global Inc.
3 Aug 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
PNT
POINT Biopharma Global Inc.
13 Jun 23
Departure of Directors or Certain Officers
4:45pm
8-K
zaew4z3f21gql 8t7a
5 Jun 23
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
1zfhmig0m46cpdyb
7 Feb 23
Entry into a Material Definitive Agreement
8:00am
8-K
358g0lmwrllyn
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
8-K
b3n0lfmcwp2r169a
13 Sep 22
POINT Biopharma Announces Proposed Public Offering of Common Stock
4:12pm
8-K
48i6a063tk
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
8-K
k4ilk3roo04jkcx h0
6 Sep 22
POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
8:11am
8-K
jpkg04haylja0
3 Jun 22
Submission of Matters to a Vote of Security Holders
1:21pm
8-K
h0lvdwe
16 May 22
Other Events
8:20am
8-K
vewcosyhlre9o
12 May 22
Entry into a Material Definitive Agreement
8:42am
8-K
rnz2kyt3e q9gbdiia
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
8-K
lqyzonp ts4
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
6l84tfgxt
15 Feb 22
Other Events
4:15pm
8-K
hzouo7pi3r1
10 Dec 21
Departure of Directors or Certain Officers
8:17am
8-K
h0udr
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
fyenqng6tt qbzgab2
19 Nov 21
Regulation FD Disclosure
8:09am